Выходит 6 номеров в год
ISSN Печать: 1040-8401
ISSN Онлайн: 2162-6472
Indexed in
Diverse Functional Activity of CD83+ Monocyte-Derived Dendritic Cells and the Implications for Cancer Vaccines
Краткое описание
Antigen-loaded dendritic cells (DCs) provide key regulatory signals to T cells during a developing antitumor response. In addition to providing costimulation, mature DC provides cytokine and chemokine signals that can define the T1 vs T2 nature of the antitumor T-cell response as well as whether T cells engage in direct interactions with tumor cells. In serum-free culture conditions that hasten the differentiation of monocytes into mature DCs, certain agents, such as CD40L, accelerate phenotypic maturation (e.g., CD83 and costimulatory molecule expression) without influencing the acquisition of Dc1/Dc2 characteristics. In contrast, exposure to serum-free medium and interferon-g (IFN-g) rapidly influences CD83+ DCs to secrete high levels of IL-12, IL-6, and MIP-1b, and promotes Dc1 differentiation. In contrast, CD83+ DCs matured in serum-free medium in the absence of IFN-g, or in the presence of calcium signaling agents, prostaglandin-E2, or IFN-a, produce no IL-12, scant IL-6, and prodigious IL-8, MDC, and TARC, and promote Dc2 differentiation. T cells sensitized via IL-12–secreting, peptide-pulsed DCs secrete cytokines when subsequently exposed to relevant peptide-pulsed antigen-presenting cells (APCs) or to HLA-compatible tumor cells endogenously expressing the peptide. In contrast, T cells sensitized via IL-12 nonsecreting DC were limited to antigenic reactivation through APC contact rather than tumor cell contact. Therefore, the development of antitumor responses can be dramatically influenced not only by costimulation, but also by the cytokine and chemokine production of DCs, which must be considered in the development of cancer vaccines.
-
Daniel Volker, Naujokat Cord, Sadeghi Mahmoud, Wiesel Manfred, Hergesell Olaf, Opelz Gerhard, Association of Circulating Interleukin (IL)-12– and IL-10–Producing Dendritic Cells with Time Posttransplant, Dose of Immunosuppression, and Plasma Cytokines in Renal-Transplant Recipients, Transplantation, 79, 11, 2005. Crossref
-
Kirkwood John M., Butterfield Lisa H., Tarhini Ahmad A., Zarour Hassane, Kalinski Pawel, Ferrone Soldano, Immunotherapy of cancer in 2012, CA: A Cancer Journal for Clinicians, 62, 5, 2012. Crossref
-
SVANE INGE MARIE, SOOT METTE LINE, BUUS SOREN, JOHNSEN HANS E., Clinical application of dendritic cells in cancer vaccination therapy, APMIS, 111, 7-8, 2003. Crossref
-
Brusa Davide, Carletto Sara, Cucchiarale Giuseppina, Gontero Paolo, Greco Alessandro, Simone Mariagrazia, Ferrando Ugo, Tizzani Alessandro, Matera Lina, Prostatectomy restores the maturation competence of blood dendritic cell precursors and reverses the abnormal expansion of regulatory T lymphocytes, The Prostate, 71, 4, 2011. Crossref
-
Tangen Jon-Magnus, AMA Tryggestad, G Hetland, Stimulation of human monocytic cells by the medicinal mushroom Agaricus blazei Murill induces expression of cell surface markers associated with activation and antigen presentation, Applied Scientific Reports, 1, 1, 2014. Crossref
-
Faries Mark B., Czerniecki Brian J., Dendritic cells in melanoma immunotherapy, Current Treatment Options in Oncology, 6, 3, 2005. Crossref
-
Han Ruiling, Zhu Junming, Yang Xiangliang, Xu Huibi, Surface modification of poly(D,L-lactic-co-glycolic acid) nanoparticles with protamine enhanced cross-presentation of encapsulated ovalbumin by bone marrow-derived dendritic cells, Journal of Biomedical Materials Research Part A, 96A, 1, 2011. Crossref
-
Holmstrøm Kim, Pedersen Ayako Wakatsuki, Claesson Mogens Helweg, Zocca Mai-Britt, Jensen Simon Skjøde, Identification of a microRNA signature in dendritic cell vaccines for cancer immunotherapy, Human Immunology, 71, 1, 2010. Crossref
-
Schaue Dörthe, Kachikwu Evelyn L., McBride William H., Cytokines in Radiobiological Responses: A Review, Radiation Research, 178, 6, 2012. Crossref
-
Kalinski Pawel, Mailliard Robbie B, Giermasz Adam, Zeh Herbert J, Basse Per, Bartlett David L, Kirkwood John M, Lotze Michael T, Herberman Ronald B, Natural killer–dendritic cell cross-talk in cancer immunotherapy, Expert Opinion on Biological Therapy, 5, 10, 2005. Crossref
-
Michielsen Adriana J., Hogan Andrew E., Marry Joseph, Tosetto Miriam, Cox Fionnuala, Hyland John M., Sheahan Kieran D., O'Donoghue Diarmuid P., Mulcahy Hugh E., Ryan Elizabeth J., O'Sullivan Jacintha N., Dieli Francesco, Tumour Tissue Microenvironment Can Inhibit Dendritic Cell Maturation in Colorectal Cancer, PLoS ONE, 6, 11, 2011. Crossref
-
Osada Takuya, Clay Timothy M., Woo Christopher Y., Morse Michael A., Lyerly H. Kim, Dendritic Cell-Based Immunotherapy, International Reviews of Immunology, 25, 5-6, 2006. Crossref
-
Janic Branislava, Iskander A. S. M., Rad Ali M., Soltanian-Zadeh Hamid, Arbab Ali S., Feldmesser Marta, Effects of Ferumoxides – Protamine Sulfate Labeling on Immunomodulatory Characteristics of Macrophage-like THP-1 Cells, PLoS ONE, 3, 6, 2008. Crossref
-
Park Shin-Young, Choi Woo Hyuck, Kim Yong Bum, Ha Chang Su, Lee Hyunah, Kwon Young-Do, Choi Ok-Mi, Lee Young-Joon, Koh Woo Suk, Potential Side Effects of Dendritic Cells Pulsed with Allogenic Melanoma Cell Lysate in Mice, International Journal of Toxicology, 26, 1, 2007. Crossref
-
Anguille Sébastien, Smits Evelien L., Bryant Christian, Van Acker Heleen H., Goossens Herman, Lion Eva, Fromm Phillip D., Hart Derek N., Van Tendeloo Viggo F., Berneman Zwi N., Rosenblum Michael G., Dendritic Cells as Pharmacological Tools for Cancer Immunotherapy, Pharmacological Reviews, 67, 4, 2015. Crossref
-
Robson Neil C., Phillips David J., McAlpine Tristan, Shin Amanda, Svobodova Suzanne, Toy Tracey, Pillay Vinochani, Kirkpatrick Naomi, Zanker Damien, Wilson Kathy, Helling Imke, Wei Heng, Chen Weisan, Cebon Jonathan, Maraskovsky Eugene, Activin-A: a novel dendritic cell–derived cytokine that potently attenuates CD40 ligand–specific cytokine and chemokine production, Blood, 111, 5, 2008. Crossref
-
Kalinski Pawel, Wieckowski Eva, Muthuswamy Ravikumar, de Jong Esther, Generation of Stable Th1/CTL-, Th2-, and Th17-Inducing Human Dendritic Cells, in Dendritic Cell Protocols, 595, 2010. Crossref
-
Katzman Shoshana D., Gallo Eugenio, Hoyer Katrina K., Abbas Abul K., Differential Requirements for Th1 and Th17 Responses to a Systemic Self-Antigen, The Journal of Immunology, 186, 8, 2011. Crossref
-
Faries Mark B, Morton Donald L, Therapeutic Vaccines for Melanoma, BioDrugs, 19, 4, 2005. Crossref
-
Okur Fatma V., Brenner Malcolm K., Cellular Immunotherapy of Cancer, in Immunotherapy of Cancer, 651, 2010. Crossref
-
Kalinski Pawel, Urban Julie, Narang Rahul, Berk Erik, Wieckowski Ewa, Muthuswamy Ravikumar, Dendritic cell-based therapeutic cancer vaccines: what we have and what we need, Future Oncology, 5, 3, 2009. Crossref
-
PONSAERTS P, VAN TENDELOO V F I, BERNEMAN Z N, Cancer immunotherapy using RNA-loaded dendritic cells, Clinical and Experimental Immunology, 134, 3, 2003. Crossref
-
Prabakaran Indira, Menon Chandrakala, Xu Shuwen, Gómez-Yafal Alicia, Czerniecki Brian J., Fraker Douglas L., Mature CD83+ dendritic cells infected with recombinant gp 100 vaccinia virus stimulate potent antimelanoma T cells, Annals of Surgical Oncology, 9, 4, 2002. Crossref
-
Xu Shuwen, Koski Gary K., Faries Mark, Bedrosian Isabelle, Mick Rosemarie, Maeurer Markus, Cheever Martin A., Cohen Peter A., Czerniecki Brian J., Rapid High Efficiency Sensitization of CD8+ T Cells to Tumor Antigens by Dendritic Cells Leads to Enhanced Functional Avidity and Direct Tumor Recognition Through an IL-12-Dependent Mechanism , The Journal of Immunology, 171, 5, 2003. Crossref
-
Ponsaerts Peter, Van den Bosch Glenn, Cools Nathalie, Van Driessche Ann, Nijs Griet, Lenjou Marc, Lardon Filip, Van Broeckhoven Christine, Van Bockstaele Dirk R., Berneman Zwi N., Van Tendeloo Viggo F. I., Messenger RNA Electroporation of Human Monocytes, Followed by Rapid In Vitro Differentiation, Leads to Highly Stimulatory Antigen-Loaded Mature Dendritic Cells, The Journal of Immunology, 169, 4, 2002. Crossref